Results 141 to 150 of about 15,347 (322)
Mid-continental magnetic declination: A 200-year record starting with Lewis and Clark
Robert E. Criss
openalex +1 more source
Large and kinematically unbiased samples of G- and K-type stars. V - Evolved stars in the selected areas at + 15-deg declination [PDF]
O. J. Eggen
openalex +1 more source
ABSTRACT Objective Cognitive impairment, fatigue, and depression are common in multiple sclerosis (MS), potentially due to disruption of regional functional connectivity caused by white matter (WM) lesions. We explored whether WM lesions functionally connected to specific brain regions contribute to these MS‐related manifestations.
Alessandro Franceschini +7 more
wiley +1 more source
II. Results of a preliminary comparison of certain curves of the Kew and Stonyhurst declination magnetographs [PDF]
W. Sidgreaves, Balfour Stewart
openalex +1 more source
On the estimation of the true mean inclinations when declinations are unknown [PDF]
M. Westphal +2 more
openalex +1 more source
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen +6 more
wiley +1 more source
An Analytical Method for Mechanical Analysis of Offshore Pipelines during Lifting Operation. [PDF]
Wang Z, Chen Y, Gao Q, Li F.
europepmc +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

